Skip to main content

Table 1 Percent of occurrence and transition probabilities

From: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial

Parameter

Percent

Weekly transition probability

CCO + SSD healing rate*

  

Weeks 1, 6, 9, and 11

5.0

0.05

Weeks 2, 4, and 12

10.0

0.10

Weeks 3, 5, 7, 10, and 19-52

0.0

0.00

Week 8

15.0

0.15

Weeks 13-18

6.9

0.07

Control healing rate*

  

Weeks 1-2, 4, 6-7, 9, 11, and 26-52

0.0

0.00

Week 3

15.0

0.15

Weeks 5 and 10

5.0

0.05

Weeks 8 and 12

11.0

0.11

Weeks 13-25

5.6

0.06

Ulcer recurrence †

  

Weeks 1-52

47.1

0.01

All-cause mortality ‡

0.0147

<0.01

  1. CCO, clostridial collagenase ointment; SSD, serial sharp debridement.
  2. *NCT01408277, Briggs et al. [31-33].
  3. †Persson et al. [34].
  4. ‡Centers for Disease Control for 2010 for persons 35–95 years [30].